Table 1. Baseline characteristics of cohort.
| Age (years), mean (sd) | 69 (10.2) |
|---|---|
| Sex | |
| Female | 1887 (63%) |
| Male | 1101 (37%) |
| Race | |
| White | 619 (21%) |
| Black | 725 (24%) |
| Hispanic | 1577 (53%) |
| Other | 67 (2%) |
| BMI (kg/m2) | |
| <20 | 152 (5%) |
| 20–24 | 782 (26%) |
| 25–30 | 1232 (41%) |
| >30 | 822 (28%) |
| Smoking Status | |
| Never Smoker | 1404 (47%) |
| Former Smoker | 1084 (36%) |
| Current Smoker | 498 (17%) |
| Comorbidities | |
| Diabetes Mellitus | 634 (21%) |
| Hypertension | 2196 (73%) |
| Any Cardiac Disease | 704 (24%) |
| Estimated GFR (ml/min/1.73m2) | |
| eGFRcr, mean (sd) | 75 ± 19 |
| eGFRcys, mean (sd) | 52 ± 17 |
| Antihypertensive Use | |
| Diuretic | 465 (16%) |
| Beta blocker | 355 (12%) |
| Calcium channel blocker | 596 (20%) |
| ACE inhibitor | 491 (16%) |
sd = standard deviation, BMI = body mass index, GFR = glomerular filtration rate, eGFRcr = creatinine-based estimated GFR using the CKD-EPI 2009 equation, eGFRcys = cystatin C-based estimated GFR using the CKD-EPI 2012 equation, ACE = angiotensin converting enzyme